{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:15:15Z","timestamp":1790252115205,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xkme.2023.100681","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:40:33Z","timestamp":1685187633000},"page":"100681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment Options for Anemia in Kidney Transplant Patients: A Review"],"prefix":"10.1016","volume":"5","author":[{"given":"Mario","family":"Bonomini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Di Liberato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sirolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.06.030","article-title":"New treatment approaches for the anemia of CKD","volume":"67","author":"Bonomini","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12882-019-1244-y","article-title":"Post renal transplantation anemia: causes, severity and their association with graft and patient survival","volume":"20","author":"Schechter","year":"2019","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100681_bib3","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/ndt\/gfl457","article-title":"A\u00a0prospective study of anaemia and long-term outcomes in kidney transplant recipients","volume":"21","author":"Winkelmayer","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"32","key":"10.1016\/j.xkme.2023.100681_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007735","article-title":"Posttransplantation anemia in kidney transplant recipients: a retrospective cohort study","volume":"96","author":"Gafter-Gvili","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.xkme.2023.100681_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000496140","article-title":"Posttransplantation anemia in kidney transplant recipients","volume":"142","author":"Gafter-Gvili","year":"2019","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ndt\/gfaa219","article-title":"Haematological disorders following kidney transplantation","volume":"37","author":"Malyszko","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10157-009-0170-x","article-title":"Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients","volume":"13","author":"Kawada","year":"2009","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.transproceed.2021.11.025","article-title":"Quality of life in long-term renal transplant patients: a controversial subject","volume":"54","author":"Molina","year":"2022","journal-title":"Transplant Proc"},{"issue":"suppl 3","key":"10.1016\/j.xkme.2023.100681_bib9","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfn653","article-title":"Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP)","volume":"24","author":"Locatelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2023.100681_bib11","doi-asserted-by":"crossref","unstructured":"Guzzo I, Atkinson MA. Anemia after kidney transplantation. Pediatr Nephrol. Published online October 25, 2022. https:\/\/doi.org\/10.1007\/s00467-022-05743-7","DOI":"10.1007\/s00467-022-05743-7"},{"issue":"7","key":"10.1016\/j.xkme.2023.100681_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: a European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.xkme.2023.100681_bib13","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.tp.0000205174.97275.b5","article-title":"Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors","volume":"81","author":"Shah","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.xkme.2023.100681_bib14","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.transproceed.2014.10.035","article-title":"Parameters influencing blood erythropoietin levels of renal transplant recipients during the early post-transplantation period","volume":"46","author":"Kalantzi","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.xkme.2023.100681_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2006.07.006","article-title":"Anemia after renal transplantation","volume":"48","author":"Afzali","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2023.100681_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1987.241","article-title":"Dynamics of erythropoiesis following renal transplantation","volume":"32","author":"Besarab","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2023.100681_bib17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/ndt\/gfaa123","article-title":"Iron deficiency after kidney transplantation","volume":"36","author":"Vinke","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0012.1994.tb00377.x","article-title":"Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients","volume":"8","author":"Moore","year":"1994","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/asheducation-2010.1.281","article-title":"Hematologic disorders after solid organ transplantation","volume":"2010","author":"Smith","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000842","article-title":"The current therapeutic approach for anaemia after kidney transplant","volume":"32","author":"Nissaisorakarn","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.xkme.2023.100681_bib21","first-page":"611","article-title":"Infections in the first year after renal transplant","volume":"80","author":"Saad","year":"2020","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.xkme.2023.100681_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101667","article-title":"Parvovirus B19 infection in kidney transplant recipients: A prospective study in a teaching hospital in Shanghai, China","volume":"74","author":"Huang","year":"2022","journal-title":"Transpl Immunol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100681_bib23","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/jcpt.13775","article-title":"Management of drug-induced neutropenia, thrombocytopenia, and anaemia after solid organ transplantation: a comprehensive review","volume":"47","author":"Baradaran","year":"2022","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.xkme.2023.100681_bib24","first-page":"5501","article-title":"Drug-induced megaloblastic, aplastic, and hemolytic anemias: current concepts of pathophysiology and treatment","volume":"11","author":"Al Qahtani","year":"2018","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib25","first-page":"1382","article-title":"Chronic use of proton-pump inhibitors and iron status in renal transplant recipients","volume":"8","author":"Douwes","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2009.12.042","article-title":"The role of the renin-angiotensin system in the regulation of erythropoiesis","volume":"56","author":"Vlahakos","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib27","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1172\/JCI119769","article-title":"Angiotensin II stimulates proliferation of normal early erythroid progenitors","volume":"100","author":"Mrug","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00394-014-0749-1","article-title":"Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice","volume":"54","author":"Tajima","year":"2015","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.xkme.2023.100681_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1992.tb05644.x","article-title":"Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers","volume":"34","author":"Pratt","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xkme.2023.100681_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000507272","article-title":"Competing effects of renin angiotensin system blockade and sodium-glucose cotransporter-2 inhibitors on erythropoietin secretion in diabetes","volume":"51","author":"Marathias","year":"2020","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","article-title":"Posttransplant erythrocytosis","volume":"63","author":"Vlahakos","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2023.100681_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1399-0012.2011.01545.x","article-title":"Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis","volume":"26","author":"Kamar","year":"2011","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib33","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.transproceed.2012.09.033","article-title":"Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes","volume":"44","author":"Marc\u00e9n","year":"2012","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11255-010-9854-0","article-title":"Anemia at one year is an independent risk factor of graft survival","volume":"44","author":"De Andrade","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/15269248221145046","article-title":"A\u00a0systematic review and meta-analysis of posttransplant anemia with overall mortality and cardiovascular outcomes among kidney transplant recipients","volume":"33","author":"Mekraksakit","year":"2023","journal-title":"Prog Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14602","article-title":"Absence of hemoglobin increase is associated with reduced graft survival after kidney transplantation","volume":"36","author":"Goldman","year":"2022","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.2014.335","article-title":"Cardiovascular risk assessment in kidney transplantation","volume":"87","author":"Hart","year":"2015","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.xkme.2023.100681_bib38","first-page":"1200","article-title":"Cardiovascular risk after kidney transplantation: causes and current approaches to a relevant burden","volume":"12","author":"Reggiani","year":"2022","journal-title":"J\u00a0Pers Med"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","article-title":"Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia","volume":"14","author":"Rigatto","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100681_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/IJNRD.S314313","article-title":"Association of post transplantation anaemia and persistent secondary hyperparathyroidism with diastolic function in stable kidney transplant recipients","volume":"14","author":"Hsu","year":"2021","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","article-title":"Anemia is associated with mortality in kidney-transplanted patients\u2014a prospective cohort study","volume":"7","author":"Molnar","year":"2007","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2023.100681_bib45","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1681\/ASN.2006010027","article-title":"Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality","volume":"17","author":"Imoagene-Oyedeji","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100681_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6987240","article-title":"Posttransplant anemia as a prognostic factor of mortality in kidney-transplant recipients","volume":"2017","author":"Majernikova","year":"2017","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11255-015-1069-y","article-title":"Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes","volume":"47","author":"Huang","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100681_bib48","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1111\/ctr.12220","article-title":"Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study","volume":"27","author":"Schjelderup","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.xkme.2023.100681_bib49","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1681\/ASN.2016080926","article-title":"Serum iron protects from renal postischemic injury","volume":"28","author":"Vaugier","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100681_bib50","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1046\/j.1600-6143.2004.00604.x","article-title":"Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients","volume":"4","author":"Winkelmayer","year":"2004","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.xkme.2023.100681_bib51","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/tri.12821","article-title":"Iron deficiency, anemia, and mortality in renal transplant recipients","volume":"29","author":"Eisenga","year":"2016","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.xkme.2023.100681_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002818","article-title":"Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: a cohort study","volume":"16","author":"Eisenga","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.xkme.2023.100681_bib53","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","article-title":"Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation","volume":"8","author":"Baia","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib54","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100681_bib55","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.ajkd.2021.09.017","article-title":"Recent and emerging therapies for iron deficiency in anemia of CKD: a review","volume":"79","author":"Bazeley","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ncp.10662","article-title":"Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota?","volume":"37","author":"Ribeiro","year":"2021","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.xkme.2023.100681_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2017.02.114","article-title":"Gut microbiota and renal transplant outcome","volume":"90","author":"Ardalan","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/j.ajkd.2016.04.018","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: an updated systematic review and meta-analysis","volume":"68","author":"Shepshelovich","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1399-0012.2012.01602.x","article-title":"Intravenous iron supplementation after kidney transplantation","volume":"26","author":"Rozen-Zvi","year":"2012","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.xkme.2023.100681_bib60","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/TP.0b013e318248375a","article-title":"A\u00a0randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation","volume":"93","author":"Mudge","year":"2012","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5414\/CNP71125","article-title":"Safety and tolerability of ferric carboxymaltose (FCM) for treatment of iron deficiency in patients with chronic kidney disease and in kidney transplant recipients","volume":"71","author":"Grimmelt","year":"2009","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib62","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/bcp.14643","article-title":"Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside\u2014a systematic review and meta-analysis","volume":"87","author":"Schaefer","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib63","first-page":"65","article-title":"Ferric carboxymaltose-induced hypophosphataemia after kidney transplantation","volume":"75","author":"Sari","year":"2017","journal-title":"Neth J Med"},{"key":"10.1016\/j.xkme.2023.100681_bib64","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2020-11-3","article-title":"Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review","volume":"10","author":"Kassianides","year":"2021","journal-title":"Drugs Context"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib65","article-title":"Extended literature review of the role of erythropoietin stimulating agents (ESA) use in the management of post renal transplant anaemia","volume":"7","author":"Alshamsi","year":"2022","journal-title":"Transplant Rep"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.TP.0000150370.51700.99","article-title":"Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation","volume":"79","author":"Van Biesen","year":"2005","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib68","first-page":"44","article-title":"Effect of erythropoietin on kidney allograft survival: early use after transplantation","volume":"6","author":"Nafar","year":"2012","journal-title":"Iran J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.6002\/ect.2018.0283","article-title":"Treating posttransplant anemia with erythropoietin improves quality of life but does not affect progression of chronic kidney disease","volume":"18","author":"Pile","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib70","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1681\/ASN.2011060546","article-title":"Correction of postkidney transplant anemia reduces progression of allograft nephropathy","volume":"23","author":"Choukroun","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2023.100681_bib71","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/ndt\/gfy365","article-title":"The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial","volume":"34","author":"Tsujita","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.xkme.2023.100681_bib72","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/tri.13885","article-title":"CANDLE-KIT Trial Investigators. Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2\u00a0\u00d7 2 factorial, open-label, randomized clinical trial","volume":"34","author":"Obi","year":"2021","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.xkme.2023.100681_bib73","first-page":"14","article-title":"Erythropoiesis stimulating agents and reno-protection: a meta-analysis","volume":"18","author":"Elliott","year":"2017","journal-title":"BCM Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib74","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ki.2011.473","article-title":"Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury","volume":"81","author":"Cassis","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2023.100681_bib75","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival","volume":"28","author":"Purroy","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/tri.12506","article-title":"Perioperative administration of high-dose recombinant human erythropoietin for delayed graft function prevention in kidney transplantation: a meta-analysis","volume":"28","author":"Vlachopanos","year":"2015","journal-title":"Transpl Int"},{"issue":"suppl 2","key":"10.1016\/j.xkme.2023.100681_bib77","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100681_bib78","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","article-title":"KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for anemia in CKD","volume":"62","author":"Kliger","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2023.100681_bib79","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xkme.2023.100681_bib80","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xkme.2023.100681_bib81","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xkme.2023.100681_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.854850","article-title":"Early post-transplant red blood cell transfusion is associated with an increased risk of transplant failure: a nationwide French study","volume":"13","author":"Gaiffe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.xkme.2023.100681_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101807","article-title":"Impact of early blood transfusion after kidney transplantation on the clinical outcomes and allograft survival","volume":"77","author":"Silva","year":"2023","journal-title":"Transpl Immunol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100681_bib84","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamasurg.2018.1565","article-title":"Association of perioperative red blood cell transfusions with venous thromboembolism in a north American registry","volume":"153","author":"Goel","year":"2018","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.xkme.2023.100681_bib85","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1111\/trf.17154","article-title":"The association of venous thromboembolism with blood transfusion in kidney transplant patients","volume":"62","author":"Massicotte-Azarniouch","year":"2022","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.xkme.2023.100681_bib86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000480304","article-title":"Venous thromboembolism and the risk of death and graft loss in kidney transplant recipients","volume":"46","author":"Lam","year":"2017","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2023.100681_bib87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrneph.2015.82","article-title":"Anaemia in kidney disease: harnessing hypoxia responses to therapy","volume":"11","author":"Koury","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100681_bib88","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.transproceed.2022.02.004","article-title":"Therapeutic effect of roxadustat on patients with posttransplant anemia","volume":"54","author":"Miki","year":"2022","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.xkme.2023.100681_bib89","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.21037\/apm-21-2916","article-title":"Efficacy and safety of roxadustat in the treatment of renal allograft anemia patients: a case series","volume":"10","author":"Li","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"2","key":"10.1016\/j.xkme.2023.100681_bib90","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.transproceed.2021.10.022","article-title":"Experience with the use of a novel agent, hypoxia-inducible factor prolyl hydroxylase inhibitor, for posttransplant anemia in renal transplant recipients: a case report","volume":"54","author":"Naganuma","year":"2022","journal-title":"Transplant Proc"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:25:57Z","timestamp":1762910757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2590059523000973"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100681","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Options for Anemia in Kidney Transplant Patients: A Review","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100681"}}